| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |